Western blotting analysis showed that SM-164 markedly enhanced Doxorubicin-mediated activation of caspase-3 and cleaved PARP accumulation in this HCC cell line (Fig. 5c). The gene discussed is CASP3; the disease is hepatocellular carcinoma.